JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB207607

Anti-HIF-2-alpha antibody [EPR19656]

Be the first to review this product! Submit a review

|

(13 Publications)

Rabbit Recombinant Monoclonal HIF-2-alpha antibody. Suitable for IP, WB, ICC/IF and reacts with Human samples. Cited in 13 publications.

View Alternative Names

BHLHE73, HIF2A, MOP2, PASD2, EPAS1, Endothelial PAS domain-containing protein 1, EPAS-1, Basic-helix-loop-helix-PAS protein MOP2, Class E basic helix-loop-helix protein 73, HIF-1-alpha-like factor, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, PAS domain-containing protein 2, bHLHe73, HLF, HIF-2-alpha, HIF2-alpha

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells, untreated or treated with deferoxamine mesylate salt (1mM, 24h), labeling HIF-2-alpha with ab207607 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing nuclear staining on HeLa cells treated with deferoxamine mesylate salt (1mM, 24h).

The nuclear counterstain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

Immunoprecipitation - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)
  • IP

Unknown

Immunoprecipitation - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)

HIF-2-alpha was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) cell treated with 1mM DFO for 24h, cell lysate 10 μg with ab207607 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab207607 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.

Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) cell lysate (10 μg) treated with 1mM DFO for 24h

Lane 2 : ab207607 IP in DFO treated HeLa cell lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab207607 in HeLa cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 75 seconds

All lanes:

Immunoprecipitation - Anti-HIF-2-alpha antibody [EPR19656] (ab207607)

Predicted band size: 96 kDa

false

Western blot - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)
  • WB

Supplier Data

Western blot - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)

Blocking/Dilution buffer : 5% NFDM/TBST.

The molecular weight observed is consistent with the literature, and the expression level can be induced under hypoxia or treated with hypoxia mimetic chemicals such as DFO (PMID : 25587023, 10934146, 23958427 and 21571835).

All lanes:

Western blot - Anti-HIF-2-alpha antibody [EPR19656] (ab207607) at 1/1000 dilution

Lane 1:

Untreated HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg

Lane 2:

Whole cell lysate of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with 1mM deferoxamine (DFO) mesylate salt for 24h at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 96 kDa

Observed band size: 110 kDa

false

Exposure time: 3min

Western blot - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)
  • WB

Supplier Data

Western blot - Anti-HIF-2-alpha antibody [EPR19656] (AB207607)

Blocking/Dilution buffer : 5% NFDM/TBST.

The molecular weight observed is consistent with the literature, and the expression level can be induced under hypoxia or treated with hypoxia mimetic chemicals such as CoCl2 (PMID : 21571835, 10934146 and 23958427).

All lanes:

Western blot - Anti-HIF-2-alpha antibody [EPR19656] (ab207607) at 1/1000 dilution

Lane 1:

Untreated HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg

Lane 2:

Whole cell lysate of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with 100μM CoCl2 for 24h at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 96 kDa

Observed band size: 110 kDa

false

Exposure time: 3min

  • Carrier free

    Anti-HIF-2-alpha antibody [EPR19656] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19656

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIF-2-alpha also known as hypoxia-inducible factor 2-alpha or EPAS1 plays a significant role in cellular response to oxygen levels. Mechanically HIF-2-alpha functions as a transcription factor that activates certain genes when oxygen is low. The protein typically weighs around 118 kDa. It is expressed in various tissues but particularly in endothelial cells and some neuronal tissues. These sites highlight its importance in organs requiring tight regulation of oxygen.
Biological function summary

HIF-2-alpha regulates the expression of genes involved in energy metabolism and angiogenesis. The protein forms a complex by dimerizing with the HIF-1-beta subunit which is necessary for transcriptional activity. Through this complex formation and activity it influences processes such as erythropoiesis and regulates factors like vascular endothelial growth factor (VEGF). Therefore HIF-2-alpha contributes to the adaptation of cells and tissues under hypoxic conditions.

Pathways

HIF-2-alpha engages in the hypoxia signaling pathway playing an essential part by modulating gene expression in response to low oxygen availability. This role impacts other proteins such as HIF-1-alpha sharing overlapping functions but with distinct target genes. Additionally HIF-2-alpha is involved in the mTOR pathway which influences cell growth and metabolism through its interaction with the nutrient-sensing regulatory pathway.

Researchers have linked HIF-2-alpha with conditions like renal cell carcinoma and pulmonary hypertension. The protein's dysregulation can lead to altered expression of angiogenic factors promoting tumor growth and survival. In particular its connection with VEGF exemplifies its role in these pathologies by facilitating aberrant blood vessel formation. Such interactions further highlight the potential of HIF-2-alpha as a therapeutic target in disease modulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor involved in the induction of oxygen regulated genes. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation requires recruitment of transcriptional coactivators such as CREBBP and probably EP300. Interaction with redox regulatory protein APEX1 seems to activate CTAD (By similarity).
See full target information EPAS1

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

World journal of gastrointestinal oncology 17:105213 PubMed40547177

2025

Endothelial Per-Arnt-Sim domain-containing protein 1 expression is correlated with poor prognosis and promotes invasion and metastasis in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wang Xu,Wang Li,Jia Ru

Journal of cellular and molecular medicine 28:e70241 PubMed39661026

2024

LYRM2 Promotes the Growth and Metastasis of Hepatocellular Carcinoma via Enhancing HIF-1α-Dependent Glucose Metabolic Reprogramming.

Applications

Unspecified application

Species

Unspecified reactive species

Bingfu Fan,Yueqin Zhang,Lu Zhou,Zhongchun Xie,Jie Liu,Chengwu Zhang,Changwei Dou

Journal of the American Heart Association 13:e036757 PubMed39494580

2024

Super-Enhancer-Driven Syndecan-4 Regulates Intercellular Communication in Hypoxic Pulmonary Hypertension.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoying Wang,Xiangrui Zhu,Wei Huang,Zhaosi Wang,Jian Mei,Langlin Ou,Yunwei Chen,Cui Ma,Lixin Zhang

Advanced healthcare materials 13:e2402973 PubMed39396375

2024

Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yihao Zhu,Yajian Li,Xuwen Li,Yuan Yu,Lingpu Zhang,Hanchen Zhang,Can Chen,Dong Chen,Mingshuai Wang,Nianzeng Xing,Feiya Yang,Wahafu Wasilijiang,Xiongjun Ye

The Journal of biological chemistry 300:105535 PubMed38072043

2023

FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Dongjun Yang,Qixiang Li,Peifen Lu,Dongliang Wu,Wenyang Li,Xingjun Meng,Mengying Xing,Wenbing Shangguan,Bing Chen,Jie Yang,Zhihong Zhang,Zengjun Wang,David C S Huang,Quan Zhao

The Journal of clinical investigation 133: PubMed38038129

2023

CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.

Applications

Unspecified application

Species

Unspecified reactive species

Shengnan Wang,Radhika Iyer,Xiaohua Han,Juncheng Wei,Na Li,Yang Cheng,Yuanzhang Zhou,Qiong Gao,Lingqiang Zhang,Ming Yan,Zhaolin Sun,Deyu Fang

Scientific reports 13:11588 PubMed37463949

2023

Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma.

Applications

Unspecified application

Species

Unspecified reactive species

Sinan Karakaya,Lisa Gunnesson,Erik Elias,Paula Martos-Salvo,Mercedes Robledo,Ola Nilsson,Bo Wängberg,Frida Abel,Sven Påhlman,Andreas Muth,Sofie Mohlin

Frontiers in cell and developmental biology 9:779169 PubMed35096814

2022

SIPA1 Enhances Aerobic Glycolysis Through HIF-2α Pathway to Promote Breast Cancer Metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Chenguang Yao,Jun Weng,Lingyun Feng,Wanjun Zhang,Yan Xu,Peijing Zhang,Yoshimasa Tanaka,Li Su

Journal of cellular biochemistry 122:524-537 PubMed33438770

2021

Fibronectin assembly regulates lumen formation in breast acini.

Applications

Unspecified application

Species

Unspecified reactive species

Carina Magdaleno,Trenton House,Jogendra S Pawar,Sophia Carvalho,Narendiran Rajasekaran,Archana Varadaraj

Scientific reports 10:18560 PubMed33122751

2020

HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl.

Applications

Unspecified application

Species

Unspecified reactive species

Carina Magdaleno,Leah Dixon,Narendiran Rajasekaran,Archana Varadaraj
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com